1. Home
  2. EVOK vs VRAX Comparison

EVOK vs VRAX Comparison

Compare EVOK & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • VRAX
  • Stock Information
  • Founded
  • EVOK 2007
  • VRAX 2013
  • Country
  • EVOK United States
  • VRAX United Kingdom
  • Employees
  • EVOK N/A
  • VRAX N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • EVOK Health Care
  • VRAX Health Care
  • Exchange
  • EVOK Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • EVOK 7.1M
  • VRAX 7.3M
  • IPO Year
  • EVOK 2013
  • VRAX 2022
  • Fundamental
  • Price
  • EVOK $4.81
  • VRAX $1.66
  • Analyst Decision
  • EVOK
  • VRAX
  • Analyst Count
  • EVOK 0
  • VRAX 0
  • Target Price
  • EVOK N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • VRAX 256.7K
  • Earning Date
  • EVOK 03-13-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • EVOK N/A
  • VRAX N/A
  • EPS Growth
  • EVOK N/A
  • VRAX N/A
  • EPS
  • EVOK N/A
  • VRAX N/A
  • Revenue
  • EVOK $8,617,036.00
  • VRAX $84,872.00
  • Revenue This Year
  • EVOK $97.35
  • VRAX $5,169.18
  • Revenue Next Year
  • EVOK $99.52
  • VRAX $66.97
  • P/E Ratio
  • EVOK N/A
  • VRAX N/A
  • Revenue Growth
  • EVOK 100.35
  • VRAX 7.03
  • 52 Week Low
  • EVOK $3.54
  • VRAX $0.60
  • 52 Week High
  • EVOK $12.32
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 59.77
  • VRAX 42.25
  • Support Level
  • EVOK $4.68
  • VRAX $1.56
  • Resistance Level
  • EVOK $4.94
  • VRAX $1.86
  • Average True Range (ATR)
  • EVOK 0.28
  • VRAX 0.19
  • MACD
  • EVOK 0.06
  • VRAX -0.04
  • Stochastic Oscillator
  • EVOK 73.58
  • VRAX 26.31

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: